GridAI Technologies (GRDX) vs NextCure (NXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NextCure (NXTC) has outperformed GridAI Technologies (GRDX) over the past year, gaining 7.1% versus a gain of 0.0%. Over five years, NXTC leads with a -93.7% price change compared with -100.0% for GRDX. NextCure is the larger company by market cap ($30.0 million vs $29.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | NXTC |
|---|---|---|
| Share price | $4.12 | $6.56 |
| Market cap | $29.38M | $30.03M |
| 1-day change | -1.20% | +15.39% |
| YTD return | -11.59% | -53.77% |
| 1-year return | 0.00% | +7.07% |
| 5-year return | -99.99% | -93.74% |
| EPS (TTM) | $-5.65 | $-8.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $15.74 |
| 52-week low | $1.87 | $1.55 |
| Distance from 52-week high | -40.54% | -58.32% |
| Average volume | 101.59K | 2.11M |
| Shares outstanding | 7.13M | 4.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GRDX vs NXTC FAQ
Which is bigger, GridAI Technologies or NextCure?
NextCure (NXTC) is larger, with a market capitalization of $30.03M compared with $29.38M for GridAI Technologies (GRDX).
Which stock has performed better over the past year, GRDX or NXTC?
NXTC returned +7.07% over the past 12 months, compared with 0.00% for GRDX (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and NextCure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.